Key statistics
As of last trade, 180 Life Sciences Corp (ATNF:NAQ) traded at 1.97, 50.69% above the 52 week low of 1.31 set on May 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.01 |
---|---|
High | 2.01 |
Low | 1.86 |
Bid | 1.95 |
Offer | 1.99 |
Previous close | 2.03 |
Average volume | 61.61k |
---|---|
Shares outstanding | 1.03m |
Free float | 998.39k |
P/E (TTM) | -- |
Market cap | 2.08m USD |
EPS (TTM) | -28.16 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 15:54 BST.
More ▼
- 180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
- 180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
- 180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
- 180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
- 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
- 180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan
- 180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives
- 180 Life Sciences Announces Review of Strategic Alternatives
More ▼